Inner Mongolia Furui Medical Science Co., Ltd.

SZSE:300049 Voorraadrapport

Marktkapitalisatie: CN¥10.4b

Inner Mongolia Furui Medical Science Inkomsten in het verleden

Verleden criteriumcontroles 3/6

Inner Mongolia Furui Medical Science has been growing earnings at an average annual rate of 24.4%, while the Pharmaceuticals industry saw earnings growing at 9% annually. Revenues have been growing at an average rate of 10.2% per year. Inner Mongolia Furui Medical Science's return on equity is 11.1%, and it has net margins of 9.8%.

Belangrijke informatie

24.4%

Groei van de winst

23.7%

Groei van de winst per aandeel

Pharmaceuticals Groei van de industrie10.9%
Inkomstengroei10.2%
Rendement op eigen vermogen11.1%
Nettomarge9.8%
Laatste winstupdate30 Sep 2024

Recente prestatie-updates uit het verleden

Recent updates

Subdued Growth No Barrier To Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049) With Shares Advancing 35%

Oct 17
Subdued Growth No Barrier To Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049) With Shares Advancing 35%

Here's Why We Think Inner Mongolia Furui Medical Science (SZSE:300049) Might Deserve Your Attention Today

Sep 02
Here's Why We Think Inner Mongolia Furui Medical Science (SZSE:300049) Might Deserve Your Attention Today

Inner Mongolia Furui Medical Science Co., Ltd.'s (SZSE:300049) Intrinsic Value Is Potentially 30% Above Its Share Price

Jul 21
Inner Mongolia Furui Medical Science Co., Ltd.'s (SZSE:300049) Intrinsic Value Is Potentially 30% Above Its Share Price

With EPS Growth And More, Inner Mongolia Furui Medical Science (SZSE:300049) Makes An Interesting Case

May 24
With EPS Growth And More, Inner Mongolia Furui Medical Science (SZSE:300049) Makes An Interesting Case

We Think Inner Mongolia Furui Medical Science (SZSE:300049) Can Manage Its Debt With Ease

Apr 29
We Think Inner Mongolia Furui Medical Science (SZSE:300049) Can Manage Its Debt With Ease

Investors Still Waiting For A Pull Back In Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049)

Feb 28
Investors Still Waiting For A Pull Back In Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049)

Opbrengsten en kosten

Hoe Inner Mongolia Furui Medical Science geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

SZSE:300049 Opbrengsten, kosten en inkomsten (CNY Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 241,32713059798
30 Jun 241,27213356296
31 Mar 241,23413155089
31 Dec 231,15410252482
30 Sep 231,09711052676
30 Jun 231,08410950474
31 Mar 231,04210248769
01 Jan 231,0099848171
30 Sep 221,0179848277
30 Jun 229608646470
31 Mar 229319244469
01 Jan 228989541565
30 Sep 218489037157
30 Jun 218328936661
31 Mar 217806434863
31 Dec 208086236366
30 Sep 208175038965
30 Jun 208084239761
31 Mar 208624738567
31 Dec 198324337861
30 Sep 19858141574
30 Jun 19865341077
31 Mar 198663241167
31 Dec 188673540665
30 Sep 188247134364
30 Jun 187997030581
31 Mar 188446337271
31 Dec 178236138160
30 Sep 1788211741531
30 Jun 178861174430
31 Mar 178581214230
31 Dec 168271214070
30 Sep 167091003500
30 Jun 16671993360
31 Mar 16608922870
31 Dec 15604922770
30 Sep 15649902950
30 Jun 156681082890
31 Mar 15634902800
31 Dec 14646872790
30 Sep 14567392700
30 Jun 14564152740
31 Mar 1453372570
31 Dec 1352352560

Kwaliteitswinsten: 300049 has high quality earnings.

Groeiende winstmarge: 300049's current net profit margins (9.8%) are lower than last year (10.1%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: 300049's earnings have grown significantly by 24.4% per year over the past 5 years.

Versnelling van de groei: 300049's earnings growth over the past year (18.2%) is below its 5-year average (24.4% per year).

Winst versus industrie: 300049 earnings growth over the past year (18.2%) exceeded the Pharmaceuticals industry -1.2%.


Rendement op eigen vermogen

Hoge ROE: 300049's Return on Equity (11.1%) is considered low.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden